Journal list menu
IssueCancer Communications: Volume 42, Issue 2
81-187February 2022
Export Citations
Download PDFs
ISSUE INFORMATION
EDITORIAL
Lipid droplets: could they be involved in cancer growth and cancer–microenvironment communications?
- Pages: 83-87
- First Published: 13 January 2022
REVIEWS
Ferroptosis in cancer and cancer immunotherapy
- Pages: 88-116
- First Published: 08 February 2022
New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer
- Pages: 117-140
- First Published: 12 January 2022
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy
- Pages: 141-163
- First Published: 09 January 2022
This review highlights the recent progress of inorganic nanomaterials in cancer photoimmunotherapy. Phototherapy, immunotherapy and innovative nanomaterials represent three of the novel technological advancement in cancer therapy. The combination of these methods will largely maximize the therapeutic efficacy and minimize the shortcoming of each treatment modality.
LETTERS TO THE EDITOR
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
- Pages: 164-169
- First Published: 04 December 2021
Hepatitis B virus-associated follicular lymphoma presents T-cell inflamed phenotype and response to lenalidomide
- Pages: 170-174
- First Published: 01 December 2021
Association between antipsychotic agents and risk of lung cancer: a nested case-control study
- Pages: 175-178
- First Published: 04 January 2022
Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials
- Pages: 179-183
- First Published: 15 January 2022
Impact of statins on the survival of patients with cancer: a nationwide population-based cohort study in South Korea
- Pages: 184-187
- First Published: 08 January 2022
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)